AC IMMUNE RECEIVES FDA FAST TRACK DESIGNATION FOR ANTI-ALPHA-SYNUCLEIN ACTIVE IMMUNOTHERAPY, ACI-7104, TO TREAT EARLY PARKINSON’S DISEASE (PD)

Reuters · 3d ago

Please log in to view news